Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoling Shengji Granule for amyotrophic lateral sclerosis
CTR20253326Phase 3Active
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 3 trial of Huoling Shengji Granules in amyotrophic lateral sclerosis (ALS), sponsored by Shanghai University of Traditional Chinese Medicine. Started Dec 2025; status: active.
02
Drugs
Huoling Shengji Granules
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on CTR20253326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253326.